Status:
COMPLETED
QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Radiation-Induced Telangiectasias
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to see how the look of telangiectasias (small dilated blood vessels) on radiated breast skin when altered by the pulsed dye laser affects a patient's overall well being. ...
Eligibility Criteria
Inclusion
- Locally advanced breast cancer patients treated with surgery and adjuvant radiation
- Telangiectasias in the radiation field of the treated breast
- Patients 18 years or older
Exclusion
- Non English speaking
- Current oral steroid use or receiving daily therapeutic anticoagulation (e.g. Coumadin, Lovenox)
- Breast/s reconstructed with implant in the area of previous radiation
- Pregnancy or lactation
- Previous laser treatment of telangiectasias
- Presence of a sun tan in the area
- Fitzpatrick skin types V, VI
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01803516
Start Date
February 1 2013
End Date
February 1 2018
Last Update
February 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065